Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0359920040230060920
Korean Journal of Nephrology
2004 Volume.23 No. 6 p.920 ~ p.926
A Multi-Center Phase 3 Clinical Trial to Assess the Influence to Bleeding and Anticoagulant Effect of Nafamostat Mesilate (Futhan) in Hemodialysis Patients with High Bleeding-Risk
±èÇöö/Kim HC
Çѽ¿±/±èÇü±Ô/Á¶¿ø¿ë/¼º¼ö¾Æ/¹Ú¼ö±æ/ÀåÀç¿ø/Han SY/Kim HK/Cho WY/Sung SA/Park SK/Chang JW
Abstract
KEYWORD
Hemodialysis, Anticoagulation, Nafamostat mesilate (Futhan), Bleedingrisk
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø